ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,917.17
0.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) News

Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:JAZZ
DateTimeSourceHeadlineSymbolCompany
07/05/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
01/05/202421:10PR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
01/05/202421:10PR Newswire (US)Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:JAZZJazz Pharmaceuticals PLC
01/05/202421:05PR Newswire (US)Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
24/04/202421:05PR Newswire (US)Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
17/04/202421:15PR Newswire (US)Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
10/04/202412:45PR Newswire (US)Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual MeetingNASDAQ:JAZZJazz Pharmaceuticals PLC
02/04/202412:30PR Newswire (US)Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract CancerNASDAQ:JAZZJazz Pharmaceuticals PLC
12/03/202420:15PR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
12/03/202420:15PR Newswire (US)Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
08/03/202423:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
08/03/202402:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
08/03/202402:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
08/03/202402:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
08/03/202402:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
07/03/202423:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
06/03/202400:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
01/03/202420:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:JAZZJazz Pharmaceuticals PLC
28/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JAZZJazz Pharmaceuticals PLC
28/02/202421:05PR Newswire (US)Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
28/02/202421:05PR Newswire (US)Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial GuidanceNASDAQ:JAZZJazz Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:JAZZ

Your Recent History

LSE
GOLD
LSE
ALL
Atlantic Lithium
LSE
PET
Petrel Resources
LSE
AHT
Ashtead
LSE
ENQ
Enquest
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved